Health & Fitness
Health and Fitness
Health and Fitness
Thu, March 8, 2012
Wed, March 7, 2012
Neurocrine Biosciences to Present at The 24th Annual Roth Conference
Neurocrine Biosciences to Present at The 24th Annual Roth Conference -- SAN DIEGO, March 7, 2012 /PRNewswire/ --
Neurocrine Biosciences to Present at The 24th Annual Roth Conference
Live Audio Webcast Tuesday, March 13, 2012
SAN DIEGO, March 7, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: [ NBIX ]) announced today that Tim Coughlin, Vice President and Chief Financial Officer of Neurocrine Biosciences, will be presenting at the 24th Annual Roth Conference in Laguna Niguel.
The live presentation takes place on Tuesday, March 13 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. The presentation will be webcast and may be accessed on the Company's website at [ http://www.neurocrine.com ].
If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, tardive dyskinesia, uterine fibroids, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at [ http://www.neurocrine.com ].
SOURCE Neurocrine Biosciences, Inc.
[ Back to top ] RELATED LINKS
[ http://www.neurocrine.com ]
